Company intelligence / Profile preview

LUTZ | ABEL

Munich, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

LUTZ | ABEL is an active German commercial law firm, not a biotech, pharma, or healthcare operating company. The firm provides legal advisory services across areas such as venture capital, M&A, construction, public procurement, litigation, employment, and technology-related matters. It appears to serve clients in multiple industries, including life sciences, but its own business is legal services rather than developing therapeutics, medical products, or healthcare technologies. For biotech analyst purposes, this entity should be classified as a professional-services firm with sector exposure, not as a life sciences company with a drug pipeline.

Industry: Consulting

Beyond the preview

Go deeper on LUTZ | ABEL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LUTZ | ABEL.

Explore the full profile